Search - tctmd.com

Displaying 261 - 280 of 311

Sort: Relevancy | Date

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? No Cell Works. Genes are the Answer.

Presenter: Nabil Dib, Philippe Menasché, Marc S. Penn

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiac Progenitor Cells Are the Only One!

Presenter: Nabil Dib, Philippe Menasché, Timothy D. Henry

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Combination of Cells for Additive Effects: This Is the Key!

Presenter: Nabil Dib, Philippe Menasché, Jay H Traverse

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiopoietic Commitment Is the Key!

Presenter: Nabil Dib, Philippe Menasché, Amit Patel

October 15, 2015

Presentation TCT 2015

TWENTE: A Prospective Randomized Trial of a Durable-Polymer Zotarolimus-Eluting Stent Versus a Durable-Polymer Everolimus-Eluting Stent in Patients With Coronary Artery Disease Five-Year Outcomes

Presenter: Bernard J. Gersh, Thomas F. Luscher, Clemens von Birgelen

October 14, 2015

Presentation TCT 2015

Ischemic Heart Disease and Acute Coronary Syndrome

Presenter: Hugh J. Linnehan, Bernard J. Gersh

October 13, 2015

Presentation TCT 2015

Kawasaki Disease Treated With BRS

Presenter: Jun-Jack Cheng, Yutaka Hikichi, Juey-Jen Hwang, Teguh Santoso, Wasan Udayachalerm, Robert-Jan van Geuns

October 13, 2015

Presentation TCT 2015

The Netherlands Presents: A Case Demonstration of Coronary Flow Capacity to Document Ischemic Heart Disease

Presenter: Morton J. Kern, Jan J. Piek, Tim P. van de Hoef

October 12, 2015

News Conference News TCT 2015

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

Yael L. Maxwell

October 12, 2015

News Conference News TCT 2015

Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award

October 12, 2015

News Features TCT 2014

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

Todd Neale

October 24, 2014

News Conference News TCT 2014

Thoughtful Insights at TCT: Dealing With Complex CAD Cases

Todd Neale

October 17, 2014

News Conference News TCT 2014

Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation

Todd Neale

October 10, 2014

Presentation TCT 2014

TCT 314: Prevalence Of Coronary Microvascular Dysfunction Amongst Patients with Chest Pain and Nonobstructive Coronary Artery Disease

Presenter: Thomas F. Luscher, Jaskanwal Sara

September 16, 2014

Presentation TCT 2014

TCT 653: Association Between Native Coronary Artery Disease Progression and In-Stent Neoatherosclerosis: A Long-term Angiographic and Optical Coherence Tomography Cohort Study

Presenter: Thomas F. Luscher, Masanori Taniwaki

September 16, 2014

News Conference News TCT 2014

Marie-Claude Morice, MD, Receives 2014 Master Clinical Operator Award

September 15, 2014

News Conference News TCT 2014

PCI for CTO Ups Survival vs. Medical Therapy, CABG

September 14, 2014

Presentation TCT 2014

Complications During Catheterization of Adults with Congenital Heart Disease

Presenter: Liliana R. Grinfeld, Robert W. Yeh, Chun Huie Lin

September 13, 2014

News Conference News TCT 2013

Triple Antiplatelet Therapy with Cilostazol Increases Tachycardia, Arrhythmias

November 04, 2013

News Conference News TCT 2013

HYBRID: Hybrid Revascularization Shows Safety, Effectiveness vs. CABG in Multivessel CAD

October 31, 2013

Advertisement

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? No Cell Works. Genes are the Answer.

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiac Progenitor Cells Are the Only One!

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Combination of Cells for Additive Effects: This Is the Key!

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiopoietic Commitment Is the Key!

TWENTE: A Prospective Randomized Trial of a Durable-Polymer Zotarolimus-Eluting Stent Versus a Durable-Polymer Everolimus-Eluting Stent in Patients With Coronary Artery Disease Five-Year Outcomes

Ischemic Heart Disease and Acute Coronary Syndrome

Kawasaki Disease Treated With BRS

The Netherlands Presents: A Case Demonstration of Coronary Flow Capacity to Document Ischemic Heart Disease

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

Thoughtful Insights at TCT: Dealing With Complex CAD Cases

Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation

TCT 314: Prevalence Of Coronary Microvascular Dysfunction Amongst Patients with Chest Pain and Nonobstructive Coronary Artery Disease

TCT 653: Association Between Native Coronary Artery Disease Progression and In-Stent Neoatherosclerosis: A Long-term Angiographic and Optical Coherence Tomography Cohort Study

Marie-Claude Morice, MD, Receives 2014 Master Clinical Operator Award

PCI for CTO Ups Survival vs. Medical Therapy, CABG

Complications During Catheterization of Adults with Congenital Heart Disease

Triple Antiplatelet Therapy with Cilostazol Increases Tachycardia, Arrhythmias

HYBRID: Hybrid Revascularization Shows Safety, Effectiveness vs. CABG in Multivessel CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content